Vitt Daniel

President and CEO, DirectorIMMUNIC, INC. (IMUX) · full profile →Form 4 · filed Mar 6, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
0 non-derivative · 6 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 4, 2024Disposed to issuer(D)10K0
Mar 4, 2024Disposed to issuer(D)65K0
Mar 4, 2024Grant(A)485K485K
Mar 4, 2024Disposed to issuer(D)80K0
Mar 4, 2024Disposed to issuer(D)115K0
Mar 4, 2024Disposed to issuer(D)215K0

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193805-24-000322) within minutes of acceptance. Every field above traces to the original document. Verify it directly: